ISSN 3105-6628(Print)
ISSN 3105-6636(Online)
版权信息

ISSN 3105-6628(Print)
ISSN 3105-6636(Online)
CODEN:MZABB7
(国际标准连续出版物标识符·
全球唯一标识符)
分配机构:美国化学文摘社(CAS)

编委会
主编
郭宇辰
同行评议专家

副主编
孙  浩  邵子辰  芦  颖
胡艺昕  顾  丽  章宇轩
马  琪  孟明哲  季  萌
(以上排名不分先后顺序)
编委

编委会助理
侯琳
期刊主页
在线投稿
申请编委/副主编/同行评议专家
索引/检索/存档
DOI
Sci Online
欧亚科学期刊索引(ESJI)
Editing and Publishing
Macau Sino-Foreign Medical Publishing Limited(MSFMP)
Address
7th Floor,D, No.19,Palawak
Lane, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
http://myzlx.scionline2025.com

 

首頁 -> 期刊简介

中文刊名:《免疫肿瘤学》

英文刊名:Immuno-Oncology

国际刊号:ISSN 3105-6628(印刷版)/ ISSN 3105-6636(网络版)

出版模式:金色开放获取(Gold OA),适用CC BY 4.0协议(全文永久免费)

出版机构:Macau Sino-Foreign Medical Publishing Limited

出版频率:双月刊

投稿语言:中文(需附英文标题、摘要、关键词、作者单位及姓名)

核心定位
《免疫肿瘤学》是一本聚焦肿瘤免疫学基础研究与临床转化的前沿学术期刊。本刊致力于推动肿瘤免疫治疗领域的创新突破,重点探索免疫检查点机制、肿瘤微环境调控、细胞治疗技术及生物标志物开发等关键科学问题。我们特别鼓励采用多学科交叉的研究方法,整合免疫学、肿瘤学、分子生物学及生物信息学等领域的前沿技术,为肿瘤免疫治疗的临床实践提供坚实的理论依据和创新策略。

约稿范围
本刊欢迎以下研究方向的投稿:

免疫检查点抑制剂的作用机制与耐药研究

CAR-T/NK/TCR-T等细胞治疗技术的创新与应用

肿瘤免疫微环境的动态调控机制

肿瘤新生抗原与个体化免疫治疗

免疫治疗生物标志物的发现与验证

免疫治疗相关不良反应的机制与管理

肿瘤疫苗与联合治疗策略

微生物组与肿瘤免疫应答

放射治疗与免疫治疗的协同效应

免疫治疗临床试验与真实世界研究

全球诚邀编委/副主编/同行评议专家/主编
我们诚挚邀请全球免疫肿瘤学领域的专家学者加入我们的学术团队,共同推动学科发展。在线申请请访问:
http://tg.scionline2025.com/01/bw.asp

在线投稿
欢迎通过以下链接提交稿件:
http://tg.scionline2025.com/01/

目标与愿景
本刊旨在成为免疫肿瘤学领域的国际权威学术平台,促进基础研究向临床治疗的快速转化。我们致力于构建全球化的学术合作网络,为研究者、临床医师和产业专家提供高水平的交流平台,推动肿瘤免疫治疗的创新发展,造福全球患者。

全球数据索引计划
本刊为所有发表论文注册专属DOI标识,并正在申请纳入以下重要学术数据库:

Science Citation Index Expanded (SCIE)

MEDLINE/PubMed

Scopus

Embase

DOAJ (Directory of Open Access Journals)

Google Scholar

百度学术

万方数据

维普资讯

澳门虚拟图书馆

龙源期刊网

超星学术平台

长江文库

新华网学术中国

CNKI 中国知网

 

 

Immuno-Oncology Call for Papers

Journal Information

Journal Title (English): Immuno-Oncology

Journal Title (Chinese): 《免疫肿瘤学》

ISSN: 3105-6628 (print) / 3105-6636 (online)

Publishing Model: Gold Open Access (under CC BY 4.0 license)

Publisher: Macau Sino-Foreign Medical Publishing Limited

Publication Frequency: Bimonthly

Language of Submission: Chinese (must include English title, abstract, keywords, and author affiliations/names)

Core Focus
Immuno-Oncology is a pioneering academic journal focusing on basic research and clinical translation in tumor immunology. The journal is dedicated to advancing innovative breakthroughs in the field of cancer immunotherapy, with particular emphasis on exploring key scientific issues including immune checkpoint mechanisms, tumor microenvironment regulation, cell therapy technologies, and biomarker development. We particularly encourage multidisciplinary research approaches that integrate cutting-edge technologies from immunology, oncology, molecular biology, and bioinformatics to provide solid theoretical foundations and innovative strategies for clinical practice in cancer immunotherapy.

Scope
We welcome submissions in the following areas:

Mechanisms of Immune Checkpoint Inhibitors and Resistance Studies

Innovation and Application of Cell Therapy Technologies (CAR-T/NK/TCR-T, etc.)

Dynamic Regulation Mechanisms of Tumor Immune Microenvironment

Tumor Neoantigens and Personalized Immunotherapy

Discovery and Validation of Immunotherapy Biomarkers

Mechanisms and Management of Immune-Related Adverse Events

Cancer Vaccines and Combination Therapy Strategies

Microbiome and Tumor Immune Responses

Synergistic Effects of Radiotherapy and Immunotherapy

Clinical Trials and Real-World Evidence in Immunotherapy

Global Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editor-in-Chief
We cordially invite experts and scholars in the field of immuno-oncology worldwide to join our academic team and collectively advance disciplinary development. Apply online at:
http://tg.scionline2025.com/01/bw.asp

Online Submission
Please submit your manuscripts via:
http://tg.scionline2025.com/01/

Aims and Vision
Our goal is to establish Immuno-Oncology as an internationally authoritative academic platform in the field, promoting the rapid translation of basic research into clinical therapy. We are committed to building a global academic collaboration network, providing researchers, clinicians, and industry experts with a high-level exchange platform, driving innovation in cancer immunotherapy, and benefiting patients worldwide.

Global Indexing Plan
The journal registers unique DOI identifiers for all published articles and is pursuing inclusion in the following major academic databases:

Science Citation Index Expanded (SCIE)

MEDLINE/PubMed

Scopus

Embase

DOAJ (Directory of Open Access Journals)

Google Scholar

Baidu Scholar

Wanfang Data

VIP Information

Macau Virtual Library

Longyuan Journal Network

Chaoxing Academic Platform

Yangtze River Database

Xinhuanet Academic China

CNKI (China National Knowledge Infrastructure)

  Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
About Quest Press / Macau Sino Int. Med. Press
关于 Quest Press 与 Macau Sino Int. Med. Press
  Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
  Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
  Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
  Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editors-in-Chief
诚邀编委、副主编、同行评审专家及主编